| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.61 | 0.009 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |